
Katie Koziara is a director of public affairs at PhRMA focusing on the organization’s executive visibility work and media relations strategy. She previously ran the social media strategy for a D.C.-based non-profit working on federal management and leadership issues. Katie earned her B.A. in Public Policy from the University of Michigan’s Ford School and is currently earning her M.A. in Fiction Writing from Johns Hopkins University.
Recent Posts
New report shows 3 in 10 Americans that have insurance still face a financial barrier to care

Today, we released the results in the first report in a series on patient experiences with the health care system. The report, titled “Barriers to Health Care Access in the Patient Experience,”...
Read More
ICYMI: Event spotlights how we can make Medicare work better for patients

Last month, PhRMA sponsored “Making Medicare Work Better for Patients,” an event hosted by The Hill. During the event, policymakers, patient advocates and biopharmaceutical leaders spoke about how we...
Read More
Out-of-pocket trends in Medicare Part D show rising costs for seniors

A new study based on IQVIA data shows alarming trends in rising out-of-pocket costs for brand medicines among Medicare Part D beneficiaries with serious and complex conditions like cancer, HIV and...
Read More
Study finds nearly half of payers believe innovative contracts can lead to lower patient out-of-pocket costs

According to a recent survey by Verpora that will be presented this week at ISPOR, nearly half of U.S. payers surveyed expressed a belief that wider implementation of innovative contracts could lead...
Read More
New data from insurers show detriments of copay accumulator adjustment programs

Commercial health insurers are starting to admit what the biopharmaceutical research industry has been warning for some time: copay accumulator adjustment programs hurt patient outcomes and shift...
Read More
Nearly 40% of commercially insured patients face half their annual out-of-pocket expenses from just one health care encounter

A new study published in Health Affairs finds that for nearly 40% of commercially insured patients, half of their annual out-of-pocket expenses for medical treatments come from just one hospital,...
Read More
New data show retail medicine prices fell in 2019

In 2019, retail prescription medicine prices declined by 0.4%, on average, according to National Health Expenditures (NHE) data from the Centers for Medicare & Medicaid Services (CMS) published...
Read More
Growth in innovative, value-based contracts holds promise for the health system and for patients

The extraordinary financial pressure COVID-19 is creating for the U.S. economy underscores the need for a renewed push toward a more value-driven health care system that prioritizes patient access...
Read More
Study finds middlemen excluded nearly 850 medicines from formularies this year

A new study from Xcenda finds that from 2014 to 2020, the number of medicines excluded by at least one of the three largest pharmacy benefit managers (PBMs) from their standard formularies increased...
Read More
Innovative contracts drive access for patients and value for the system

Our health care system is far from perfect, but there are solutions that will help address patient affordability concerns without sacrificing innovation, access or quality of care. For example,...
Read More